The Company

Grespo is a Swedish biomedical company with a focus on prevention and cure of neurodegenerative diseases such as MCI (Mild Cognitive Impairment) and Alzheimer.

Product and Market

GRE213 is intended to be used for treatment and health maintenance for people suffering from MCI, Alzheimer, Parkinson and other CNS-related conditions.



Neurogenesis decreases with age, although it is present throughout the life time. It is impacted by various factors, such as physical activity, learning and exposure to complexity.  GRE 213 has been shown to increase neurogenesis and improve cognitive functions in animal models exhibiting age related degeneration of CNS..